Health Care & Life Sciences » Biotechnology | MultiCell Technologies Inc.

MultiCell Technologies Inc. | Cash Flow

Fiscal year is December-November. All values USD Thousands.
2010
2011
2012
2013
2014
Net Income before Extraordinaries
1,166.90
1,800.70
1,358.60
1,369.40
528.80
Depreciation, Depletion & Amortization
4.60
1.10
-
-
-
Other Funds
-
-
-
12.00
104.20
Funds from Operations
597.50
1,018.00
1,251.00
1,146.90
1,113.70
Changes in Working Capital
150.30
221.10
361.40
104.30
25.30
Net Operating Cash Flow
747.90
1,239.10
889.60
1,251.10
1,088.40
Sale of Fixed Assets & Businesses
-
-
1.50
-
-
Net Investing Cash Flow
270.00
265.00
1.50
-
-
Issuance/Reduction of Debt, Net
207.90
64.10
251.90
-
-
Net Financing Cash Flow
1,255.70
1,275.10
682.20
1,197.90
1,054.70
Net Change in Cash
237.80
229.10
205.90
53.30
33.70
Free Cash Flow
747.90
1,239.10
-
1,251.10
1,088.40
Change in Capital Stock
1,047.90
1,211.00
934.10
1,185.90
950.50
Other Uses
270.00
265.00
-
-
-

About MultiCell Technologies

View Profile
Address
68 Cumberland Street
Woonsocket Rhode Island 02895
United States
Employees -
Website http://www.multicelltech.com
Updated 07/08/2019
MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. Its therapeutic development platform includes several patented techniques used to isolate, characterize and differentiate stem cells from human liver or control the immune response at transcriptional and translational levels through dsRNA-sensing molecules, such as Toll-like receptor, RIG-I-like receptor, and MDA-5 signaling. The company was founded on April 28, 1970 and is headquartered in Woonsocket, RI.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.